Henan Taloph Pharmaceutical Stock (600222) Stock Overview

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of Chinese medicines in China. The company primarily offers its products in the forms of oral liquids, tablets, capsules, fluids, and others. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Danshen oral liquid, Xiaoer Qingre Zhike oral liquid, pediatric compound Ji Neijin chewable tablets, and Huperzine A tablets. The company serves hospitals, primary medical institutions, and retail terminals. The company was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. The company was founded in 1993 and is based in Zhengzhou, China.